Skip to main content
ALVO
NASDAQ Life Sciences

Entity Closely Tied to CEO/Chairman Acquires Over $11.5M in Alvotech Shares

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
9
Price
$4.56
Mkt Cap
$1.361B
52W Low
$4.32
52W High
$13.7
Market data snapshot near publication time

Summary

An entity closely associated with Alvotech's CEO and Chairman reported a net acquisition of over $11.5 million in company shares, signaling strong insider confidence.


Key Events

  • Significant Insider Net Purchase

    ATP Holdings ehf., an entity closely associated with CEO and Chairman Róbert Wessman, reported a net acquisition of 2,701,617 Alvotech shares.

  • Substantial Investment Value

    The net purchase is valued at approximately $11.55 million (SEK 119 million), reflecting a considerable investment by a key insider.

  • Correction of Prior Announcement

    This 6-K filing corrects an earlier announcement, clarifying that the December 19, 2025 transaction was a sale, not an acquisition, resulting in a net acquisition over the two reported dates.


Analysis

ATP Holdings ehf., an entity closely associated with Alvotech's CEO and Chairman Róbert Wessman, reported a net acquisition of shares valued at approximately $11.55 million. This significant insider buying activity, representing a notable portion of the company's market capitalization, signals strong conviction from a key stakeholder. Such a substantial investment by an entity with direct ties to the top leadership can be interpreted by investors as a positive indicator of future prospects and management's belief in the company's valuation.

At the time of this filing, ALVO was trading at $4.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $4.32 to $13.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ALVO - Latest Insights

ALVO
Jun 08, 2026, 4:34 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $4.25 info
Change: +$0.065 (+2%) info
Market Cap: $1.301B info
ALVO
Jun 08, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.80
Real-time Price: $4.25 info
Change: +$0.450 (+12%) info
Market Cap: $1.301B info
ALVO
Jun 04, 2026, 9:18 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.23
Real-time Price: $4.25 info
Change: +$1.02 (+32%) info
Market Cap: $1.301B info
ALVO
May 06, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.20
Real-time Price: $4.25 info
Change: +$1.05 (+33%) info
Market Cap: $1.301B info
ALVO
Mar 30, 2026, 7:28 PM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $3.14
Real-time Price: $4.25 info
Change: +$1.11 (+35%) info
Market Cap: $1.301B info
ALVO
Mar 18, 2026, 6:15 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.78
Real-time Price: $4.25 info
Change: +$0.4696 (+12%) info
Market Cap: $1.301B info
ALVO
Mar 12, 2026, 4:09 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $3.58
Real-time Price: $4.25 info
Change: +$0.671 (+19%) info
Market Cap: $1.301B info
ALVO
Feb 05, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.28
Real-time Price: $4.25 info
Change: -$1.03 (-20%) info
Market Cap: $1.301B info
ALVO
Feb 02, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.38
Real-time Price: $4.25 info
Change: -$1.13 (-21%) info
Market Cap: $1.301B info
ALVO
Jan 29, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $5.34
Real-time Price: $4.25 info
Change: -$1.09 (-20%) info
Market Cap: $1.301B info